TS
TMDX icon

Thomas Steyer’s Transmedics TMDX Stock Holding History

Thomas Steyer’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,000
Closed -$202K – 159
2025
Q1 		$202K Buy
+3,000
New +$206K ﹤0.01% 122
2024
Q4 		– Sell
-44,000
Closed -$6.91M – 172
2024
Q3 		$6.91M Buy
44,000
+42,000
+2,100% +$6.47M 0.03% 91
2024
Q2 		$301K Buy
+2,000
New +$240K ﹤0.01% 119

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thomas Steyer's TMDX Position: Q2 2025 in Review

Thomas Steyer sold out of Transmedics (TMDX) in Q2 2025, closing a stake of 3,000 shares — an estimated $202K sold.

Thomas Steyer first reported a position in TMDX in Q2 2024 and held it in 3 quarters. The position peaked at $6.91M in Q3 2024. 368 funds tracked by Wall St. Rank hold TMDX as of Q2 2025.

  • Thomas Steyer reported no remaining Transmedics position as of Q2 2025 after selling out during the quarter.
  • Thomas Steyer sold 3,000 Transmedics shares in Q2 2025, an estimated $202K.
  • Thomas Steyer first reported a position in Transmedics in Q2 2024 and held it in 3 quarters.
  • Thomas Steyer's Transmedics position peaked at $6.91M in Q3 2024.
  • 368 funds tracked by Wall St. Rank held Transmedics as of Q2 2025.

Based on Farallon Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.